Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China Stem Cell Group is a leading healthcare enterprise in China specializing in the collection, storage, and clinical application of stem cells. The company operates several large-scale cord blood banks and has established a comprehensive network for stem cell transplantation, supporting over 10,000 clinical cases to date. It focuses on treating hematological diseases, immune system disorders, and regenerative medicine through its advanced R&D and manufacturing facilities. The group also operates the Boao Stem Cell Hospital in Hainan, the first of its kind in China dedicated to stem cell-related treatments and research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China stem cell provider.